{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "status": "retrieved", "company": "BioGaia", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:54:33Z", "company": "BioGaia AB", "title": "BioGaia AB: Delårsrapport januari - juni 2026", "category": "Halvårsrapport", "date": "2026-07-17", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q2", "period": "2026-q2", "report_key": "2026:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b94f1852ee8a829ea3e0207fbc4e66aaa&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q2\\release.txt", "attachments": [ { "label": "07169770.pdf", "url": "https://attachment.news.eu.nasdaq.com/a09d3836871f963aec0023598daa66c36", "final_url": "https://attachment.news.eu.nasdaq.com/a09d3836871f963aec0023598daa66c36", "filename": "07169770.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q2\\07169770.pdf", "content_type": "application/pdf", "size": 1250184, "sha256": "305a16923c4ec4bd578dba07552284631f214937564f6beb92376b1db05ecaca", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q2\\07169770.pdf", "filename": "07169770.pdf", "extension": ".pdf", "size": 1250184, "sha256": "305a16923c4ec4bd578dba07552284631f214937564f6beb92376b1db05ecaca", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q2\\extracted\\07169770\\07169770.txt", "text_chars": 68726, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q2\\extracted\\07169770\\07169770.extraction.json" } } ], "announcement_id": "1454617", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:54:38Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim Management Statement January - March 2026", "category": "Interim report (Q1 and Q3)", "date": "2026-05-07", "language": "en", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b0533a5948018144a306f5052d9a338c8&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "05069452.pdf", "url": "https://attachment.news.eu.nasdaq.com/af2b8772daa9469f99e7b74ad5cbf8d07", "final_url": "https://attachment.news.eu.nasdaq.com/af2b8772daa9469f99e7b74ad5cbf8d07", "filename": "05069452.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q1\\05069452.pdf", "content_type": "application/pdf", "size": 1138734, "sha256": "f9630128d5281394908b30e8d225b8ef41febd230562e39440654eb4addf2524", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q1\\05069452.pdf", "filename": "05069452.pdf", "extension": ".pdf", "size": 1138734, "sha256": "f9630128d5281394908b30e8d225b8ef41febd230562e39440654eb4addf2524", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q1\\extracted\\05069452\\05069452.txt", "text_chars": 50417, "metadata": { "page_count": 23, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2026-q1\\extracted\\05069452\\05069452.extraction.json" } } ], "announcement_id": "1440476", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:54:57Z", "company": "BioGaia AB", "title": "BioGaias Års- och hållbarhetsredovisning 2025 publicerad", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-03-30", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb00e42922afe015e51727e385e9813f9&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "03302302.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8e1cf2d5a90ae4aa7271c1b97789d396", "final_url": "https://attachment.news.eu.nasdaq.com/a8e1cf2d5a90ae4aa7271c1b97789d396", "filename": "03302302.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-annual\\03302302.pdf", "content_type": "application/pdf", "size": 9460588, "sha256": "8243dcbd6be95fe3682d686b6412e3f9c2145141ceedd0517757ea58f0873f4a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-annual\\03302302.pdf", "filename": "03302302.pdf", "extension": ".pdf", "size": 9460588, "sha256": "8243dcbd6be95fe3682d686b6412e3f9c2145141ceedd0517757ea58f0873f4a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-annual\\extracted\\03302302\\03302302.txt", "text_chars": 502591, "metadata": { "page_count": 172, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-annual\\extracted\\03302302\\03302302.extraction.json" } } ], "announcement_id": "1429896", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:55:02Z", "company": "BioGaia AB", "title": "BioGaia AB: Bokslutskommuniké januari - december 2025", "category": "Bokslutskommuniké", "date": "2026-02-12", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b528411f6ca4e98d8c3357ce2bd2a247f&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "02119838.pdf", "url": "https://attachment.news.eu.nasdaq.com/a986fafb284eabb07530281f1ae33e986", "final_url": "https://attachment.news.eu.nasdaq.com/a986fafb284eabb07530281f1ae33e986", "filename": "02119838.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q4\\02119838.pdf", "content_type": "application/pdf", "size": 1694594, "sha256": "f9cecc0d84a62449b07da8a7aa94a55b2cf859a1c426d4632760380bb4413165", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q4\\02119838.pdf", "filename": "02119838.pdf", "extension": ".pdf", "size": 1694594, "sha256": "f9cecc0d84a62449b07da8a7aa94a55b2cf859a1c426d4632760380bb4413165", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q4\\extracted\\02119838\\02119838.txt", "text_chars": 69803, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q4\\extracted\\02119838\\02119838.extraction.json" } } ], "announcement_id": "1419709", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:55:08Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim Management Statement January - September 2025", "category": "Interim report (Q1 and Q3)", "date": "2025-10-22", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd76c946c1ba0ff24d39827c9aedab832&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "10217082.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac7e460f65236456e51b65e0ea70d6926", "final_url": "https://attachment.news.eu.nasdaq.com/ac7e460f65236456e51b65e0ea70d6926", "filename": "10217082.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q3\\10217082.pdf", "content_type": "application/pdf", "size": 1603641, "sha256": "454262e4a8d8f3e9ea65078091a91d4563b43f58be541fb17e9c2894f27f5371", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q3\\10217082.pdf", "filename": "10217082.pdf", "extension": ".pdf", "size": 1603641, "sha256": "454262e4a8d8f3e9ea65078091a91d4563b43f58be541fb17e9c2894f27f5371", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q3\\extracted\\10217082\\10217082.txt", "text_chars": 64466, "metadata": { "page_count": 22, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q3\\extracted\\10217082\\10217082.extraction.json" } } ], "announcement_id": "1395738", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:55:45Z", "company": "BioGaia AB", "title": "BioGaia AB: Delårsredogörelse januari - juni 2025", "category": "Halvårsrapport", "date": "2025-07-18", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b6dc5c5903d9981475ff8e7a6e3c3b683&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "07171056.pdf", "url": "https://attachment.news.eu.nasdaq.com/a04b83ddc5403c1ab118bb0d786f9c8f7", "final_url": "https://attachment.news.eu.nasdaq.com/a04b83ddc5403c1ab118bb0d786f9c8f7", "filename": "07171056.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q2\\07171056.pdf", "content_type": "application/pdf", "size": 21585952, "sha256": "7264d0c7e224c751a100c8a46c85af4794121e4260b4b9fdfa5a850676de517a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q2\\07171056.pdf", "filename": "07171056.pdf", "extension": ".pdf", "size": 21585952, "sha256": "7264d0c7e224c751a100c8a46c85af4794121e4260b4b9fdfa5a850676de517a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q2\\extracted\\07171056\\07171056.txt", "text_chars": 61980, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q2\\extracted\\07171056\\07171056.extraction.json" } } ], "announcement_id": "1379898", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:55:52Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim Management Statement January - March 2025", "category": "Interim report (Q1 and Q3)", "date": "2025-05-07", "language": "en", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2b4d785f0fab6ba797c3813b8c4d683d&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "05068080.pdf", "url": "https://attachment.news.eu.nasdaq.com/a3d8361ffbce33ff708a051f812211bc2", "final_url": "https://attachment.news.eu.nasdaq.com/a3d8361ffbce33ff708a051f812211bc2", "filename": "05068080.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q1\\05068080.pdf", "content_type": "application/pdf", "size": 1705485, "sha256": "efba95a1bd98849983c7df87d634b175c09bee73f450adad27569eff71e352fa", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q1\\05068080.pdf", "filename": "05068080.pdf", "extension": ".pdf", "size": 1705485, "sha256": "efba95a1bd98849983c7df87d634b175c09bee73f450adad27569eff71e352fa", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q1\\extracted\\05068080\\05068080.txt", "text_chars": 44332, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2025-q1\\extracted\\05068080\\05068080.extraction.json" } } ], "announcement_id": "1361349", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:56:12Z", "company": "BioGaia AB", "title": "BioGaias Års- och hållbarhetsredovisning 2024 publicerad", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-03-26", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba9fbc5a1a2bc39f05166e706d1e12ffb&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "03266104.pdf", "url": "https://attachment.news.eu.nasdaq.com/a659c7cb22a4d411d8c9a120c517a8694", "final_url": "https://attachment.news.eu.nasdaq.com/a659c7cb22a4d411d8c9a120c517a8694", "filename": "03266104.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-annual\\03266104.pdf", "content_type": "application/pdf", "size": 16328554, "sha256": "b6b26bd10f210c160431fd7e7ccb37e1edef604f80e0b184bdec1e29b01e7f49", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-annual\\03266104.pdf", "filename": "03266104.pdf", "extension": ".pdf", "size": 16328554, "sha256": "b6b26bd10f210c160431fd7e7ccb37e1edef604f80e0b184bdec1e29b01e7f49", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-annual\\extracted\\03266104\\03266104.txt", "text_chars": 487077, "metadata": { "page_count": 174, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-annual\\extracted\\03266104\\03266104.extraction.json" } } ], "announcement_id": "1351320", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:56:16Z", "company": "BioGaia AB", "title": "BioGaia AB: Bokslutskommuniké januari - december 2024", "category": "Bokslutskommuniké", "date": "2025-02-12", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4172f0043cf7c81b540ae60f6fef8651&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "02115525.pdf", "url": "https://attachment.news.eu.nasdaq.com/a191683c1698ba8ecb55bb76a11b594d7", "final_url": "https://attachment.news.eu.nasdaq.com/a191683c1698ba8ecb55bb76a11b594d7", "filename": "02115525.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q4\\02115525.pdf", "content_type": "application/pdf", "size": 1174861, "sha256": "127f7061567704ab5ab46dae09ae513ff0fedcc3f14feb36caceb306201f12b3", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q4\\02115525.pdf", "filename": "02115525.pdf", "extension": ".pdf", "size": 1174861, "sha256": "127f7061567704ab5ab46dae09ae513ff0fedcc3f14feb36caceb306201f12b3", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q4\\extracted\\02115525\\02115525.txt", "text_chars": 64967, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q4\\extracted\\02115525\\02115525.extraction.json" } } ], "announcement_id": "1342341", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:56:22Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim Management Statement January - September 2024", "category": "Interim report (Q1 and Q3)", "date": "2024-10-22", "language": "en", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2faf185269322aa41bc6db4903706d79&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "10215246.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5f9e3a6fd7b484cdac785c13a3b39aee", "final_url": "https://attachment.news.eu.nasdaq.com/a5f9e3a6fd7b484cdac785c13a3b39aee", "filename": "10215246.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q3\\10215246.pdf", "content_type": "application/pdf", "size": 1005465, "sha256": "aca7f99a0f57f9d36604c97a47ad63bdefa968e3a6f444b56bfe428ae72b259b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q3\\10215246.pdf", "filename": "10215246.pdf", "extension": ".pdf", "size": 1005465, "sha256": "aca7f99a0f57f9d36604c97a47ad63bdefa968e3a6f444b56bfe428ae72b259b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q3\\extracted\\10215246\\10215246.txt", "text_chars": 60418, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q3\\extracted\\10215246\\10215246.extraction.json" } } ], "announcement_id": "1322543", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:56:55Z", "company": "BioGaia AB", "title": "BioGaia AB: Delårsredogörelse januari - juni 2024", "category": "Halvårsrapport", "date": "2024-07-23", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf00100284b5189f1596c92351956f2bd&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "07228177.pdf", "url": "https://attachment.news.eu.nasdaq.com/a86e096a80b25eff3995c61c6f28a27f3", "final_url": "https://attachment.news.eu.nasdaq.com/a86e096a80b25eff3995c61c6f28a27f3", "filename": "07228177.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q2\\07228177.pdf", "content_type": "application/pdf", "size": 10208124, "sha256": "1659006a6c7d3b2a4f19cf2c5a696bb0b83ddef3d90ea07f76438db231fe54e1", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q2\\07228177.pdf", "filename": "07228177.pdf", "extension": ".pdf", "size": 10208124, "sha256": "1659006a6c7d3b2a4f19cf2c5a696bb0b83ddef3d90ea07f76438db231fe54e1", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q2\\extracted\\07228177\\07228177.txt", "text_chars": 61323, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q2\\extracted\\07228177\\07228177.extraction.json" } } ], "announcement_id": "1307684", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:56:59Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim Management Statement January - March 2024", "category": "Interim report (Q1 and Q3)", "date": "2024-05-07", "language": "en", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b116cb0fcfb641bd17e9565317a8ca492&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "05064536.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0211655510db17bd018f0f8966db9316", "final_url": "https://attachment.news.eu.nasdaq.com/a0211655510db17bd018f0f8966db9316", "filename": "05064536.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q1\\05064536.pdf", "content_type": "application/pdf", "size": 824936, "sha256": "b58e72aa9d5ce162fa53e583202dee3c77742b03ad53916c23a14605eb5a490c", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q1\\05064536.pdf", "filename": "05064536.pdf", "extension": ".pdf", "size": 824936, "sha256": "b58e72aa9d5ce162fa53e583202dee3c77742b03ad53916c23a14605eb5a490c", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q1\\extracted\\05064536\\05064536.txt", "text_chars": 47905, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2024-q1\\extracted\\05064536\\05064536.extraction.json" } } ], "announcement_id": "1293846", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:57:16Z", "company": "BioGaia AB", "title": "BioGaias Års- och hållbarhetsredovisning 2023 publicerad", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-03-26", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b58360e27cec69f413f1e3c31ef5be42d&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "03262713.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5088201b525cda472e4acc61045a984b", "final_url": "https://attachment.news.eu.nasdaq.com/a5088201b525cda472e4acc61045a984b", "filename": "03262713.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-annual\\03262713.pdf", "content_type": "application/pdf", "size": 14127879, "sha256": "a6a71c2886e94573cc9cdeb39aae479adc3e45e85da176b776e3626e8eac56e2", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-annual\\03262713.pdf", "filename": "03262713.pdf", "extension": ".pdf", "size": 14127879, "sha256": "a6a71c2886e94573cc9cdeb39aae479adc3e45e85da176b776e3626e8eac56e2", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-annual\\extracted\\03262713\\03262713.txt", "text_chars": 450092, "metadata": { "page_count": 148, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-annual\\extracted\\03262713\\03262713.extraction.json" } } ], "announcement_id": "1283958", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:57:21Z", "company": "BioGaia AB", "title": "BioGaia AB: Bokslutskommuniké januari - december 2023", "category": "Bokslutskommuniké", "date": "2024-02-07", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b761d45b9700c461a7291a1a9de556ba3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "02063304.pdf", "url": "https://attachment.news.eu.nasdaq.com/a00fd3c3a42b09edf425d627810ea1bf1", "final_url": "https://attachment.news.eu.nasdaq.com/a00fd3c3a42b09edf425d627810ea1bf1", "filename": "02063304.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q4\\02063304.pdf", "content_type": "application/pdf", "size": 1074879, "sha256": "39f324794c42da88ebdefeca8fb330e35b34ce7925c9cc68821710d7b105d8ff", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q4\\02063304.pdf", "filename": "02063304.pdf", "extension": ".pdf", "size": 1074879, "sha256": "39f324794c42da88ebdefeca8fb330e35b34ce7925c9cc68821710d7b105d8ff", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q4\\extracted\\02063304\\02063304.txt", "text_chars": 65447, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q4\\extracted\\02063304\\02063304.extraction.json" } } ], "announcement_id": "1273149", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:57:26Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim report third quarter January - September 2023", "category": "Interim report (Q1 and Q3)", "date": "2023-10-20", "language": "en", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=be2c1eddecb52e700c830aef368f888d5&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "10196376.pdf", "url": "https://attachment.news.eu.nasdaq.com/a130da545503205bb4eab7b88a2e2d37d", "final_url": "https://attachment.news.eu.nasdaq.com/a130da545503205bb4eab7b88a2e2d37d", "filename": "10196376.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q3\\10196376.pdf", "content_type": "application/pdf", "size": 1058739, "sha256": "8c55e4646cbc8e6c77e7bcab075f5fbfcc723730a084858b72fe73c9533afbba", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q3\\10196376.pdf", "filename": "10196376.pdf", "extension": ".pdf", "size": 1058739, "sha256": "8c55e4646cbc8e6c77e7bcab075f5fbfcc723730a084858b72fe73c9533afbba", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q3\\extracted\\10196376\\10196376.txt", "text_chars": 56267, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q3\\extracted\\10196376\\10196376.extraction.json" } } ], "announcement_id": "1253702", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:57:34Z", "company": "BioGaia AB", "title": "BioGaia AB: Delårsredogörelse januari - juni 2023", "category": "Halvårsrapport", "date": "2023-07-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b8f607b6ae6679a602364b4095f3557f3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "07206536.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4c355f8626a91bbd579e03a7fef783d4", "final_url": "https://attachment.news.eu.nasdaq.com/a4c355f8626a91bbd579e03a7fef783d4", "filename": "07206536.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q2\\07206536.pdf", "content_type": "application/pdf", "size": 1139545, "sha256": "26d3244289d60aa06905c2995677303cf966943903c470439e06cad73f7b68ef", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q2\\07206536.pdf", "filename": "07206536.pdf", "extension": ".pdf", "size": 1139545, "sha256": "26d3244289d60aa06905c2995677303cf966943903c470439e06cad73f7b68ef", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q2\\extracted\\07206536\\07206536.txt", "text_chars": 62039, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q2\\extracted\\07206536\\07206536.extraction.json" } } ], "announcement_id": "1239465", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:57:37Z", "company": "BioGaia AB", "title": "BioGaia AB: Interim Management Statement - January - March 2023", "category": "Interim report (Q1 and Q3)", "date": "2023-05-05", "language": "en", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bfc5c33495f9d24bdfa66597f303470b7&lang=en&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "05042371.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7006e0d07d22ecb7d32825e3d7a3ea14", "final_url": "https://attachment.news.eu.nasdaq.com/a7006e0d07d22ecb7d32825e3d7a3ea14", "filename": "05042371.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q1\\05042371.pdf", "content_type": "application/pdf", "size": 965449, "sha256": "1db2e0704ca425f00305ff54076c72a261302c154bfade2c389eb3900bf16bcb", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q1\\05042371.pdf", "filename": "05042371.pdf", "extension": ".pdf", "size": 965449, "sha256": "1db2e0704ca425f00305ff54076c72a261302c154bfade2c389eb3900bf16bcb", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q1\\extracted\\05042371\\05042371.txt", "text_chars": 46630, "metadata": { "page_count": 20, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\biogaia\\nasdaq-reports\\reports\\2023-q1\\extracted\\05042371\\05042371.extraction.json" } } ], "announcement_id": "1225779", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "3b0b2f9210c481bec42551a4b3083094d56b23279abf3ec2b0c678af102e0981" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "c89a965e765610caac4d9cf6b6e1cf36cc9a9b39c9de199f6104705ad393d82e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "ace7e78668139731c40c383dedeaee47afeafa1d8018f524d689f6d5b82c6170" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 78, "new_rows": 78, "total_count": null, "from_cache": false, "body_sha256": "6d8ffbe11e661ccb419afdb4b86838558a663da3960da405afe633b90f6f2987" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=378&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 378, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "cd63740980eac7bec3d66fcc3695dbeeb992152fb0b7b35907c24e07a5fc0892" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 12, "new_rows": 12, "total_count": null, "from_cache": false, "body_sha256": "485f47658e4114160ec56113e571395ab6f952dbd3832a35fca80b0cf20fca3f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=12&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 12, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "5ffe9e16443141d8a6706e3e1c52818ff66c39ce5c4dc1e32ae98f4b4ebaaec7" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "bf957e3246cbb6bbe8671122f0b5cedea7ad5ecebe7e25d799eee6bbeb8963c0" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a87077b9925f8befe49a46e7d5bca6a3976d0a7b06015aaa54c1c4d2f87f7af4" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a6adf75d04e9b0f8abaf78b647fb60a4fd9d20327fe076aed0482197b8034a08" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 54, "new_rows": 54, "total_count": null, "from_cache": false, "body_sha256": "70c98384f98787fa516990c3b0d897101f1b4d3c91e5f6a0a2a20f5602e03be8" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=354&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 354, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "004c65f6984586b4ba54cd25478ff0d35a3782adee17c837134c5a6b94206322" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 6, "new_rows": 6, "total_count": null, "from_cache": false, "body_sha256": "da64af91c0fb1b432eaa145a6e08f2713c4dafc8996bc6f9c9c99e771935b039" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioGaia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=6&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 6, "pagination": "row-offset", "query_text": "BioGaia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bd9c05e04ff6560502e6bf3875897cb7834465fc4920a52158db62f481ce3d43" } ], "identity": { "slug": "biog-b", "instrument_id": "TX184", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/biog-b?id=TX184" }, "transport": "ordinary-http", "browser_used": false, "query_text": "BioGaia", "retrieved_at": "2026-08-04T08:57:38Z" }